BubR1 insufficiency occurs with natural aging and induces progeroid phenotypes in both mice and children with mosaic variegated aneuploidy syndrome. In response to BubR1 insufficiency, skeletal muscle, fat, and lens tissue engage p19 Arf to attenuate senescence and age-related deterioration.
INTRODUCTION
Aging is a complex biological process that increases the risk of a broad spectrum of human diseases and disorders, including diabetes, osteoporosis, arthritis, cataracts, sarcopenia, and cardiovascular and neurological disease (Campisi, 2005; Gau et al., 2011; Lotz and Caramé s, 2011) . Despite the importance of aging to human health, the molecular mechanisms underlying the progressive physiologic decline with aging remain incompletely understood (Marion et al., 2009) . Studies in animal model systems have identified various genes that promote longevity when mutated, including genes that encode components of key metabolic pathways (Kenyon, 2010) . Other efforts to understand how we age focus on genes associated with human progeria syndromes or mouse models that develop features resembling accelerated aging (Burtner and Kennedy, 2010) . One of these genes encodes for BubR1, a core component of the mitotic checkpoint that ensures accurate segregation of chromosomes by participating in the inhibition of the ubiquitin E3 ligase activity of Cdc20-activated anaphase-promoting complex in the presence of unattached chromosomes (Baker et al., 2004) . Mutant mice carrying BubR1 hypomorphic alleles (referred to as BubR1 H/H mice) that produce low amounts of the protein develop multiple progeroid and aging-associated phenotypes, including short lifespan, dwarfism, facial dysmorphisms, cataracts, sarcopenia, (subdermal) fat loss, impaired wound healing, and reduced dermal thickness (Baker et al., 2004 (Baker et al., , 2008a Hartman et al., 2007; Matsumoto et al., 2007) . Mutations in human BubR1 are associated with mosaic variegated aneuploidy (MVA), a rare syndrome that is characterized by aneuploidization and various progeroid traits, including short lifespan, short stature, cataracts, facial dysmorphisms, and mental retardation (Hanks et al., 2004; Lane et al., 2002; Matsuura et al., 2006; Suijkerbuijk et al., 2010) . Several of these age-associated features are observed in mice carrying a monoallelic BubR1 MVA mutation (Wijshake et al., 2012) . Furthermore, BubR1 levels decrease with age in various mouse tissues and sustained overexpression of BubR1 extends mouse healthspan and lifespan, which has prompted speculation that BubR1 might be a determinant of chronological aging (Baker et al., 2004 (Baker et al., , 2013 Hartman et al., 2007; Matsumoto et al., 2007) .
p16 Ink4a and p19 Arf , two biomarkers of human and rodent aging (Krishnamurthy et al., 2004) , are selectively induced in skeletal muscle, fat, and eye tissue of BubR1 progeroid mice (Baker et al., 2008b) . Genetic inactivation of p16 Ink4a or clearance of p16 Ink4a -positive cells from BubR1 progeroid mice slows functional decline of these tissues, demonstrating a causal link between accumulation of senescent cells and functional impairment in these tissues (Baker et al., 2008a (Baker et al., , 2008b (Baker et al., , 2011 , although the types of cells that are senescing have not been defined. Inactivation of p19 Arf , on the other hand, accelerates sarcopenia, fat loss, and cataract formation, implying that its induction in response to BubR1 insufficiency acts to suppress cellular stress that drives cells into a senescent state (Baker et al., 2008b) . p19 Arf accumulates in the nucleolus, where it binds NPM1 and Mdm2 to suppress tumor development by inhibiting ribosome biogenesis and initiating p53-dependent senescence and apoptosis, respectively (Conboy et al., 2003; Conboy and Rando, 2002; Kamijo et al., 1997) . The recent discovery of additional binding partners has alluded to the existence of various p53-independent cellular functions of p19 Arf (Conboy et al., 2003; Rio Frio et al., 2010) . The hypothesis that p19 Arf might exert its antiprogeroid effects in the context of BubR1 insufficiency through a p53-dependent mechanism is directly challenged by studies on other progeroid mouse strains, such as Zmpste24 null (a model for Hutchinson-Gilford progeria), Brca1 null, and Ercc1 hypomorphic mice, showing that p53 drives early aging in these models (Cao et al., 2003; Kirkwood, 2002; Maier et al., 2004; Nú ñ ez et al., 2000; Sharpless, 2004; Tyner et al., 2002; Varela et al., 2005) .
Here, we further explored the molecular basis of MVA syndrome and the potential multifaceted role of p53 in premature aging using p53-deficient BubR1 hypomorphic mice. p53 has hundreds of potential downstream target genes implicated in a wide variety of biological processes, including transient cellcycle arrest, cellular senescence, apoptosis, inhibition of angiogenesis, autophagy, metabolism, and DNA repair (el-Deiry, 1998; Nakamura, 2004; Papazoglu and Mills, 2007) . However, the impact of individual p53 target genes on (accelerated) aging remains largely unknown. We focused on the role of p21, a p53 target gene implicated in cell-cycle arrest and cellular senescence (Cheung et al., 2012; Vousden and Prives, 2009 ), using BubR1 hypomorphic mice that we bred onto a p21 null genetic background. In addition to revealing that p53 is the critical mediator of the p19 Arf -induced antiaging responses in BubR1 progeroid mice, we identify p21 as the key downstream p53 target gene through which the p53 protector function is executed in two tissues: skeletal muscle and fat. Interestingly, we find that insufficiency of BubR1 induces several senescence-associated markers in progenitor cells residing in these tissues, not in terminally differentiated cells. Senescence of these progenitors is further elevated upon deletion of p21, demonstrating that activation of p53 in BubR1 hypomorphic mice acts to mobilize antiaging responses in adipose and skeletal muscle tissue. Furthermore, we find that p21 induction in lens tissue promotes cataract formation, but that p21-independent p53 responses counteract this p21 effector function. These findings indicate that BubR1 insufficiency elicits an aging response that is counteracted by p53 and involves single or multiple p53 targets, depending on the tissue type.
RESULTS
p53 and p21 Activation in BubR1 H/H Mice Acts to Extend Lifespan p19 Arf has several diverse functions, one of which is to stabilize p53 through inhibition of Mdm2 (Conboy et al., 2003) . Since p53 has been linked to senescence and aging, we sought to determine whether the p19 Arf -dependent antiaging mechanism activated in response to BubR1 insufficiency involves p53. As a first step, we analyzed skeletal muscle, fat, and eye from 2-month-old BubR1 H/H and wild-type mice for p53 protein levels by western blot analysis. Previously, we documented that p19 Arf expression is markedly increased in these three tissues (Baker et al., 2008b) . Fat and eye extracts of BubR1 H/H mice indeed contained elevated levels of p53 protein ( Figure 1A ). We found that the p53 target p21 was also elevated in these same tissues ( Figure 1A ). Western blots of skeletal muscle extracts probed for p53 and p21 were inconclusive (data not shown), but quantitative RT-PCR (qRT-PCR) analysis demonstrated that p21 gene transcript levels were significantly increased in skeletal muscle of BubR1 H/H mice ( Figure 1B ), suggesting that p19 Arf induction resulted in p53 stabilization in this tissue as well. BubR1 H/H tissues that developed age-related pathology in a p19 Arf -independent fashion (i.e., brain and aorta) or had no age-related phenotypes (i.e., lung, pancreas, and colon) did not exhibit increased expression of p21 ( Figure S1 ). Thus, p53 and p21 appear to be selectively induced in p19 Arf -positive BubR1 H/H tissues subjected to premature aging.
To determine the role of p53 and p21 in the p19 Arf -dependent antiaging mechanism activated in response to BubR1 insufficiency, we bred BubR1 H/H mice onto a p53 (Jacks et al., 1994) or p21 (Brugarolas et al., 1995) homozygous null genetic background. Cohorts of BubR1 H/H , p53 À/À , and p21 À/À mice were used as controls. All cohorts were monitored for the development of age-related phenotypes for a period of up to 1 year. Ablation of p53 or p21 dramatically shortened the median overall survival of BubR1 H/H mice by 35% ( Figure 1C ). Additionally, the maximum lifespan of BubR1 H/H ;p53 À/À or BubR1 H/H ;p21 À/À mice was significantly decreased compared to BubR1 H/H mice ( Figure 1C ). The tumor incidence of BubR1 H/H ;p53 À/À mice was low compared to that of p53 À/À mice, with 17% of BubR1 H/H ;p53 À/À mice having tumors compared to 96% of p53 À/À mice ( Figure 1D ). Although the overall tumor latency (thymic lymphoma and osteosarcoma) was similar for BubR1 H/H ; p53 À/À and p53 À/À mice ( Figure 1E ), the latency of osteosarcoma of BubR1 H/H ;p53 À/À mice was significantly decreased, indicating that BubR1 insufficiency accelerates sarcoma formation in the absence of p53 ( Figure 1D ). No tumors were observed upon postmortem examination of BubR1 H/H ;p21 À/À mice (Figure 1D) . These data reveal that the substantial reduction in lifespan of BubR1 hypomorphic animals lacking p53 or p21 cannot be explained by accelerated tumorigenesis.
p53 Acts through p21 to Delay Progeroid Decline in Muscle and Fat Inactivation of p19 Arf accelerates sarcopenia, fat loss, and cataract formation in BubR1 H/H mice. If p53 and p21 inactivation phenocopy the effects of p19 Arf depletion, this would indicate that p53 would be the critical target of p19 Arf , and p21 that of p53. Consistent with this, we found that lordokyphosis (an abnormal rearward curvature of spine), a phenotype that in BubR1 H/H mice is caused by sarcopenia (Baker et al., 2004) , was significantly accelerated in both BubR1 H/H ;p53 À/À and BubR1 H/H ; p21 À/À mice (Figure 2A ). Gastrocnemius and abdominal muscles of 6-week-old BubR1 H/H ;p53 À/À and BubR1 H/H ;p21 À/À mice had significantly smaller fibers than those of BubR1 H/H mice (Figure 2B) , confirming that sarcopenia was indeed accelerated following the loss of p53 or p21. Lordokyphosis did not develop in p53 À/À and p21 À/À mice during the 1 year observation period (data not shown). Skinning of 6-week-old mice demonstrated that adipose tissue deposits of BubR1 H/H ;p53 À/À and BubR1 H/H ; p21 À/À mice were overtly smaller than those of BubR1 H/H mice ( Figure 2C ). The weight of the inguinal adipose tissue (IAT) revealed that this fat depot was significantly reduced ( Figure 2D ). Consistent with reduced fat and muscle volume, BubR1 H/H ; p53 À/À and BubR1 H/H ;p21 À/À mice had significantly lower body weights than BubR1 H/H mice ( Figure 2D ). The progeroid phenotypes of dermal thinning and arterial wall stiffening were not exacerbated following the loss of p53 or p21 (Figures S2A and S2B), which is consistent with the finding that p21 levels are not elevated in dermis and aorta of BubR1 H/H mice ( Figure S1 ). Collectively, these data provide evidence that induction of p21 through p19 Arf -dependent stabilization of p53 counteracts (C) Kaplan-Meier overall survival curves of the indicated mice. Asterisks denote significance compared to BubR1 H/H mice using log-rank tests. The maximum lifespan of BubR1 H/H ;p53 À/À and BubR1 H/H ;p21 À/À mice was significantly shortened compared to BubR1 H/H mice (p = 0.0226 and p = 0.0034, respectively; two-sided Wang/Allison test referring to the proportion of mice alive at the 90 th percentile survival point). (D) Tumor incidence and latency of mice indicated in (C). The time to osteosarcoma formation in BubR1 H/H ;p53 À/À mice is significantly faster than in p53 À/À mice. (E) Tumor-free survival curves of mice dying of cancer from (C). The BubR1 H/H ;p53 À/À and p53 À/À curves are both significantly different from BubR1 H/H (log-rank test). No BubR1 H/H ;p21 À/À or p21 À/À mice died of tumors over the duration of the experiment. *p < 0.05; **p < 0.01; ***p < 0.001. See also Figures S1 and S2.
aging-associated functional decline of skeletal muscle and fat tissue in response to BubR1 insufficiency.
p21 Inhibits Degeneration of Skeletal Muscle and Fat by Preventing Senescence
To provide insight into the mechanism by which p21 inactivation promotes functional decline of skeletal muscle and fat tissue of BubR1 hypomorphic mice, we asked if loss of p53 or p21 acts to promote cellular senescence, a process that has been linked to age-related pathologies in this model (Baker et al., 2008b (Baker et al., , 2011 . Fat of 5-month-old prematurely aged BubR1 H/H mice is known to express high amounts of senescenceassociated b-galactosidase (SA-b-gal), an established marker for the detection of senescent cells in cell culture and select mouse tissues (Baker et al., 2008b (Baker et al., , 2011 . Adipose tissue of BubR1 H/H mice showed relatively low SA-b-gal activity at 6 weeks of age. In contrast, fat of BubR1 H/H ;p53 À/À and BubR1 H/H ;p21 À/À mice showed high SA-b-gal activity at this age ( Figure 3A) , indicating increased senescence. In keeping with this, other markers of cellular senescence in fat were also markedly elevated, including p16 Ink4a , p19 Arf , Pai1, Igfbp2, and IL-6 (Baker et al., 2008b (Baker et al., , 2011 Krishnamurthy et al., 2004 ) ( Figure 3B ). Similarly, markers of skeletal muscle senescence, such as p16 Ink4a , p19 Arf , Igfbp2, Mmp13, and Nrg1 (Baker et al., 2008b) , were all elevated in BubR1 H/H muscles compared to wild-type muscles, and even more in BubR1 H/H ;p53 À/À and BubR1 H/H ;p21 À/À muscles (Figure 3C ). Cell proliferation, as measured using in vivo BrdU incorporation, was considerably lower in both adipose tissue and skeletal muscle of BubR1 H/H ;p53 À/À and BubR1 H/H ;p21 À/À mice than in BubR1 H/H mice ( Figure 3D ), further supporting the notion that rates of senescence were increased in these tissues. In accordance with previous observations (Baker et al., 2004 (Baker et al., , 2008a , the premature aging of these tissues is not associated with increased DNA damage ( Figures S2C and S2D ). We note that the attenuating effect of p53 or p21 on in vivo senescence in BubR1 H/H mice cannot be recapitulated in vitro using cultured BubR1 H/H mouse embryonic fibroblasts (MEFs), most likely because these cells immortalize when p53 or p21 is lacking . Collectively, the above data suggest that p53mediated activation of p21 in response to BubR1 insufficiency acts to preserve skeletal muscle and adipose tissue integrity by driving cells into a state of reversible temporal cell-cycle arrest that protects against entry into a senescent state.
p21 Attenuates Progenitor Cell Senescence in Muscle and Fat of BubR1 H/H Mice Although accumulation of senescent cells in skeletal muscle and fat of BubR1 H/H mice has been causally implicated in tissue dysfunction, the types of cells in these tissues that are subject to senescence were unknown. To address these key open questions, IAT collected from 5-month-old BubR1 H/H mice was stained for SA-b-gal, squeezed between two microscopy slides, and analyzed by light microscopy. While mature adipocytes were negative for SAb-gal, areas that appeared to track with the fat tissue vasculature were frequently positive ( Figure 4A ). These areas include endothelial cells, white blood cells, adipocyte stem cells (ASCs), and preadipocytes (PACs), collectively termed the stromal vascular fraction (SVF) (Cawthorn et al., 2012) . To determine which cells of the SVF were prone to senescence, we prepared single cells from IAT using collagenase treatment and a combination of centrifugation and fluorescence-activated cell sorting to collect mature adipocytes, endothelial cells, and a combined population of ASCs and PACs ( Figure S3A ). As expected, mature adipocytes stained negative for SA-b-gal, whereas the SVF was highly positive ( Figure S3B ). Strikingly, the relative number of ASCs/PACs in the SVF of 2-month-old BubR1 H/H mice was about 3-fold lower than in wild-type mice ( Figure 4B ). Compared to wild-type mice, p16 Ink4a transcript levels were highly elevated in the ASC/PAC cell fraction of BubR1 H/H mice, but not in adipocytes and endothelial cells ( Figure 4C ). Other markers of cellular senescence were also markedly elevated in this fraction (Figure 4D) , indicating that fat progenitor cells with low amounts of BubR1 are prone to become senescent. Senescent cells in skeletal muscle of BubR1 H/H mice do not visibly stain the tissue for SA-b-gal activity (data not shown), precluding microscopy as a means to provide insight into the kinds of cells in this tissue that are prone to senescence. In an alternative approach outlined in Figure S3C , we used collagenase treatment of skeletal muscle from 2-month-old BubR1 H/H mice followed by purification of muscle fibers and particular populations of mononuclear cells, including quiescent satellite cells (Q-SCs; muscle stem cells) and fibro/adipogenic progenitors (FAPs; a subpopulation of mononuclear cells that does not generate myofibers but facilitate myogenesis; Joe et al., 2010) . Mature skeletal muscle fibers from BubR1 H/H mice exhibited no significant increase in p16 Ink4a transcripts ( Figure 5A ), nor did Q-SCs from these mice. In contrast, the FAP pool of BubR1 H/H cells had very high p16 Ink4a transcript levels compared to their counterparts from wild-type mice ( Figure 5A ). Several additional markers of senescence in skeletal muscle were elevated in the FAP population ( Figure 5B ), indicating that progenitor cells with insufficient amounts of BubR1 are prone to senesce.
We next collected ASC/PAC and FAP populations from BubR1 H/H ;p21 À/À mice to examine whether accelerated aging in the skeletal muscle and fat of these animals correlates with increased progenitor cell senescence. All markers of senescence were significantly higher in ASCs/PACs from BubR1 H/H ;p21 À/À mice than from BubR1 H/H ( Figure 4D ). FAP populations also exhibited an even further elevation in senescence markers upon loss of p21 in BubR1 H/H ( Figure 5B ). Importantly, consistent with impaired function of FAPs, repair of cardiotoxin-induced damage of skeletal muscle tissue was already markedly impaired in BubR1 H/H ;p53 À/À and BubR1 H/H ;p21 À/À mice at a very young age ( Figure 5C ). Together, these data suggest that p21, through p53 activation, acts to protect progenitor cells from senescence due to BubR1 insufficiency in adipose and skeletal muscle tissue.
p53 Inhibits Cataractogenesis in BubR1 H/H Mice via a p21-Independent Mechanism A prominent aging-related feature of BubR1 hypomorphic mice is the development of cataracts (Baker et al., 2004) , a phenotype that is significantly accelerated following the loss of p19 Arf (Baker et al., 2008b) . We found that ablation of p53 accelerated cataract formation in BubR1 H/H mice ( Figure 6A ), which suggested that p19 Arf -mediated induction of p53 delayed age-related deterioration of lens tissue in a manner similar to that observed in skeletal muscle and fat. However, unlike in skeletal muscle and fat, the p53-dependent protective mechanism in lens was p21 independent, as genetic inactivation of p21 in BubR1 H/H mice resulted in delayed rather than exaggerated cataract formation ( Figure 6A) . To examine the potential mechanisms underlying these contrasting observations, we performed a histological assessment on lenses of 2-month-old wild-type, BubR1 H/H , BubR1 H/H ; p53 À/À , and BubR1 H/H ;p21 À/À mice. As previously documented (Baker et al., 2004) , 2-month-old BubR1 H/H mice show signs of early cataract formation, with lens epithelial cells and Morgagnian globules accumulating at the posterior part of the lens (Figures 6B and 6C) . In BubR1 H/H ;p53 À/À mice, these two pathological features were substantially worsened, which closely correlated with the earlier onset of cataracts in these animals. On the other hand, epithelial cells in the posterior of the lens were significantly reduced in BubR1 H/H ;p21 À/À mice and Morgagnian globules were rarely detected. Recent findings using an INK-ATTAC transgenic construct that allows for clearance of p16 Ink4a -positive senescent cells have shown that these cells are causally implicated in cataract formation in BubR1 H/H mice (Baker et al., 2011) . Consistent with an accelerated rate of senescence-dependent cataract formation, p16 Ink4a transcript levels in eyes of 6-week-old BubR1 H/H ;p53 À/À mice were significantly higher than those eyes of age-matched BubR1 H/H mice (Figure 6D) . A very similar increase was observed for the senescent cell marker p19 Arf (Figure 6D ). Furthermore, in accordance with decreased cataract formation due to prevention of cellular senescence, eyes of BubR1 H/H ;p21 À/À mice had significantly lower p16 Ink4a and p19 Arf transcript levels than eyes of BubR1 H/H mice ( Figure 6D ). Collectively, these data provide evidence for a tissue in which p53 acts both as an effector and an attenuator of age-related deterioration through engagement of p21-dependent and p21-independent mechanisms, respectively. We found that transcript levels of multiple effectors of p53-mediated apoptosis were significantly elevated in cataractous lenses of BubR1 H/H ( Figure 6E ), suggesting that apoptosis is a key p21-independent mechanism through which p53 attenuates cataractogenesis in BubR1 H/H mice.
DISCUSSION
p19 Arf expression markedly increases with age in various human and rodent tissues (Krishnamurthy et al., 2004) , but whether and how this tumor suppressor influences aging-related processes remains unclear. A key barrier has been the fact that p19 Arf knockout mice die of cancer before they develop age-related pathologies (Kamijo et al., 1997) . In a previous study, we bypassed this problem by studying the impact of p19 Arf disruption in BubR1 progeroid mice, which revealed that p19 Arf protects the skeletal muscle, adipose tissue, and eye of these mice against aging-related deterioration (Baker et al., 2008b) . Here, we used a genetic approach involving p53 and p21 knockout mice to dissect the molecular mechanisms underlying this protective effect, which led to four significant insights.
First, our observation that BubR1 H/H ;p53 À/À mice phenocopy BubR1 H/H ;p19 ArfÀ/À mice demonstrates that p53 is the key critical downstream target of p19 Arf . In turn, our discovery that the skeletal muscle and fat phenotypes of BubR1 H/H ;p21 À/À mice mimic those of BubR1 H/H ;p53 À/À mice reveals that p21 is the relevant target of p53 in these tissues. Both of these findings are remarkable given that p19 Arf has a myriad of binding partners implicated in diverse biological processes (Conboy et al., 2003) and that p53 has hundreds of potential transcriptional targets as well as a growing number of nontranscriptional functions (Vousden and Prives, 2009 ).
Second, it has been reported that p21 drives cellular senescence and age-related pathology in a progeroid mouse model for telomere dysfunction (Choudhury et al., 2007) . Our finding here that p21 loss accelerates skeletal muscle and fat deterioration in BubR1 progeroid mice uncovers a role for p21 as an attenuator of age-related decline. We show that engagement of p21 in these tissues reduces formation of p16 Ink4a -positive senescent cells, suggesting that p21-mediated temporary cell-cycle arrest or quiescence helps relieve the stress or damage that stimulates the p16 Ink4a -Rb pathway to establish the senescent phenotype. Studies in cultured cells revealed that p21-independent p53 activities, including p53-mediated inhibition of the mTOR pathway, counteract p21-mediated cellular senescence (Minagawa et al., 2011) . However, in the context of BubR1 insufficiency, the senescence suppressive effect seems entirely p21 dependent because p21 and p53 loss phenocopy each other in most tissues. In preliminary studies, BubR1 progeroid mice fed a diet containing the mTOR inhibitor rapamycin developed agerelated phenotypes at similar rates as mice on a control diet (T.W. and J.v.D., unpublished data), which is consistent with Figure S3 .
the notion that p21-mediated protection of skeletal muscle and fat against progeroid decline does not involve p21-independent activities of p53.
Third, the observation that disruption of p21 in BubR1 progeroid mice attenuates cataract formation provides evidence that p21 can also act as an effector of age-related deterioration in response to BubR1 insufficiency in a tissue-selective manner ( Figure S4 ). The most straightforward explanation would be that the extent or duration of p21 engagement in lens epithelial cells reaches a threshold for activation of the senescence program, but not in skeletal muscle and fat. Intriguingly, in contrast to loss of p21, loss of p53 accelerates cataract formation in BubR1 progeroid mice, characterizing p53 as a protector of age-related decline of lens tissue ( Figure S4) . A possible explanation for these contrasting effects would be that p21-independent functions of p53 induce apoptosis of damaged cells, thereby preventing the accumulation of cells in the posterior part of the lens where they are able to distort its integrity. This possibility is supported by the observation that several p53 target genes that mediate apoptosis are induced in lens epithelial cells in response to BubR1 insufficiency ( Figure 6E ). It is important to note that p53 has multiple activities other than mediating senescence and apoptosis (Vousden and Prives, 2009) . Perhaps one or more of these activities may act to facilitate proper terminal differentiation of lens epithelial cells from BubR1 progeroid mice, which would also reduce the incidence of aberrant migration of lens epithelial cells to posterior part of the lens ( Figure S4) .
Fourth, the cell types within skeletal muscle and fat of BubR1 hypomorphic mice that undergo senescence to drive progeroid tissue dysfunction were unknown. Here, we provide evidence to suggest that progenitor cells in both these tissues are highly prone to cellular senescence. We propose that the acquisition of senescence in these cell populations may contribute to aging of the tissue through two distinct mechanisms. First, senescence acts to reduce the number of progenitors capable of undergoing the remaining steps to terminal differentiation to replenish or repair tissue. Second, these senescent progenitors may promote further dysfunction of neighboring progenitor and stem cells by affecting the niche where these cells reside through the senescence-associated secretory phenotype (SASP) that senescent cells acquire. The finding that deletion of p21 increases senescence marker levels in progenitor populations of BubR1 hypomorphic mice suggests that p21 engagement ameliorates senescence-causing stress resulting from BubR1 insufficiency in these cells. One possibility is that these highly mitotic populations engage p21 as a molecular switch to remain in the cell cycle, rather than permanently withdrawing and producing a SASP. Earlier, we documented that the attenuating effect of p19 Arf ablation on in vivo senescence in skeletal muscle and fat of BubR1 H/H mice is not recapitulated by the effect on in vitro senescence in BubR1 H/H MEFs (Baker et al., 2008b) . We find that the same holds true for ablation of p53 or p21 ( Figures S2E-S2H) , underscoring that the endogenous cell signaling circuitry dictating cell fate is complex and difficult to mimic in vitro. To further advance the idea that p21 might serve as a molecular switch between senescence and transient cell-cycle arrest in response to BubR1-induced cellular stress, it will therefore be important to develop mouse models in which p21 can be deleted in a tissue-specific and temporally controllable fashion.
Our identification of p53 as a protector against aging-related pathology in BubR1 insufficient mice contrasts studies of other progeroid models, which have characterized p53 as an effector of functional decline (Kirkwood, 2002; Sharpless, 2004; Vousden and Lane, 2007) . How can these divergent roles of p53 be reconciled? Whether p53 signaling in response to DNA damage induces apoptosis, cellular senescence, or cell-cycle arrest is highly dependent on the cell or tissue type and the nature and extent of damage (Vousden and Prives, 2009 ). Likewise, the various stresses implicated in the distinct progeroid models could differentially engage p53. It is conceivable that progeroid models in which p53 loss delays tissue deterioration can induce a robust p53 transcriptional response that leads to apoptosis or senescence, leading to tissue degeneration and aging. In our model, perhaps a lower chronic triggering of the p53 pathway may avoid these potentially negative effects of cell death or senescence. Progeroid models in which p53 inactivation attenuates premature aging involve age-related features distinct from BubR1 mutant mice, raising the possibility that the tissues subjected to cellular stress are distinct, which could underlie differential consequences of p53 activation.
What might be the potential significance of our findings to natural aging? Early studies involving mutant mouse strains expressing p53 isoforms introduced the concept that p53 hyperac- tivity drives the aging process (Maier et al., 2004; Tyner et al., 2002) . The finding that p19 Arf levels increase in many human and rodent tissues further supported this idea (Krishnamurthy et al., 2004) . However, studies in normal mice subsequently suggested that p53 function actually declines with aging (Feng et al., 2007) . This, together with the finding that transgenic mice containing an extra copy of wild-type endogenous p53 and p19 Arf have an increased healthspan and lifespan (Matheu et al., 2007) , has called the proaging effect of p53 into question. Our data provide in vivo support for the emerging concept that the p19 Arf -p53 pathway plays an important role in protection against functional decline of select tissues and organs during natural aging. It will now be important to further test this concept in naturally aged wild-type mice. It should be noted that the progeroid model used in this study may be much more relevant to normal aging than previously anticipated. In normal mice, BubR1 levels decline with aging in various tissues, with late-life BubR1 protein levels in normal mice reaching levels similar to those in BubR1 H/H mice at an early age (Baker et al., 2004; Hartman et al., 2007; Matsumoto et al., 2007) . Preventing this decline by sustained high overexpression of transgenic BubR1 has recently been shown to increase lifespan and healthspan of mice (Baker et al., 2013) . Interestingly, attenuated sarcopenia in these mice is coupled with a delayed induction of both p16 Ink4a and p19 Arf .
EXPERIMENTAL PROCEDURES

Mouse Strains and MEFs
BubR1 H/H mice were generated as previously described (Baker et al., 2004) . p53 (Jacks et al., 1994) and p21 (Brugarolas et al., 1995) knockout mice were acquired from The Jackson Laboratory (Bar Harbor, ME, USA). These mice were bred to BubR1 +/H mice, and the resulting double-heterozygous mice were intercrossed to generate wild-type, BubR1 H/H , BubR1 H/H ;p21 À/À , p21 À/À , BubR1 H/H ;p53 À/À , and p53 À/À mice. Similar crosses were used to generate MEFs as previously described (Baker et al., 2008b) . MEFs were generated from trypsinized carcasses of 13.5-day-old embryos as previously described (Babu et al., 2003) . MEFs were cultured at 3% oxygen for two passages and then switched to 20% oxygen and used for experimentation at subsequent passages. All mice were on a mixed 129 3 C57BL/6 genetic background. Animals were housed in a pathogen-free barrier environment for the duration of the study. Experimental procedures involving the use of laboratory mice were reviewed and approved by the Mayo Clinic Rochester Institutional Animal Care and Use Committee.
Western Blot Analyses
Western blot analyses were carried out as previously described (Kasper et al., 1999) . Equal loading was determined using tubulin as previously described (Baker et al., 2008b) . Antibodies for senescence-associated proteins were as previously described (Baker et al., 2004 (Baker et al., , 2006 . Western blotting for gH2AX of 2-month-tissues was performed as previously described (Baker et al., 2008a) with Ponceau S to equalize protein loading.
Analysis of Progeroid Phenotypes
Biweekly checks for lordokyphosis and cataracts were as previously described (Baker et al., 2008b) . Skeletal muscle fiber diameter measurements were performed on cross-sections of gastrocnemius and abdominal muscles of 6-week-old male mice (n = 5 per genotype). A total of 50 fibers per sample were measured using a calibrated computer program (Olympus MicroSuite Five). Aorta thickness measurements were performed on crosssections of paraffin-embedded aorta isolated from 2-month-old male mice (n = 5 per genotype), and 50 random-thickness measurements were taken as described above. Dissection, histology, and measurements of dermal and adipose layers of dorsal skin were performed as described previously (Baker et al., 2004) . Measurements of body weight and IAT were performed on 6-week-old males (n = 5 per genotype). For analysis of cataract formation, 2-month-old eye tissue was embedded and sectioned through the middle of the lens. The number of cells that had migrated past the lens epithelial bow was counted (n = 8 lenses per genotype). Cardiotoxin treatment was performed on 2-month-old mice as previously described (Baker et al., 2008b) .
qRT-PCR qRT-PCR was performed as described on inguinal adipose tissue, skeletal muscle, and total eye tissue (Baker et al., 2008b) . Lens tissue was isolated from 6-month-old mice by first removing the cornea. Both lenses of the same animal were used for RNA extraction as previously described (Baker et al., 2008b) . Sequences of primers for p16 Ink4a , p19 Arf , p21, Pai1, Igfbp2, IL-6, Mmp13, and Nrg1 used were as published elsewhere (Baker et al., 2011) . Additionally, the following primer pairs were used: Puma: forward 5 0 -CGGACGGTCCTCAGCCCTCCCT-3 0 , reverse 5 0 -GCTCTTCTTGTCTCCG CCGCTCG-3 0 ; Noxa: forward 5 0 -GGTGCCAGCAGACTTGAAGGACG-3 0 , reverse 5 0 -CCAATACCAGGCATTTCCATCAACC-3 0 ; Bid: forward 5 0 -AATA GAGCCAGATTCTGAAAGTCAG-3 0 , reverse 5 0 -GCAGTTCCTTTTGTCTTCC TCCG-3 0 ; Bax: forward 5 0 -GCTTGGGAGCGGCGGGCCCACC-3 0 , reverse 5 0 -CGATCCTGGATGAAACCCTGTAGC-3 0 .
In Vivo BrdU Incorporation and SA-b-Gal Staining Analyses for in vivo BrdU incorporation were performed as previously described (Baker et al., 2008b) . Adipose tissue deposits were stained for SA-b-gal activity as previously described (Baker et al., 2004) . MEF growth rates and senescence staining was performed as previously described (Baker et al., 2008b) .
Single-Cell Isolation, Labeling, and Collection
Preparation of single cells from inguinal adipose tissue (Baker et al., 2011) and gastrocnemius muscle (Baker et al., 2013) were as previously described. ASC, PAC, and endothelial cells were isolated from adipose tissue cell suspensions using well-documented cell-type-specific cell surface markers (Cawthorn et al., 2012) . To determine the number of ASC and PAC, the total number of CD34 + ;Sca1 + cells was divided by the number of Sca-1 + cells. Labeling and isolation of Q-SCs and FAPs was performed as described elsewhere (Joe et al., 2010) . Skeletal muscle fibers were retrieved from the filter used to collect single cells after collagenase treatment. All antibodies (BD Bioscience) were used at a 1:100 dilution.
Statistical Analysis
GraphPad Prism software was used for the generation of all survival curves and for statistical analyses. Log-rank tests were used to determine overall and pairwise significance in Figures 1C, 1E , 2A, and 6A. Two-sided Wang-Allison tests were used to determine maximum lifespan changes (Wang et al., 2004) in Figure 1C . Mann-Whitney tests were used for significance in Figures 1B, 1D , 2B, 2D, 3B-3D, 6D and in Figures S1, S2A, and S2B. An unpaired t test was used for significance in Figures 4B-4D , 5A, 5B, 6C, and 6E and in Figures S2E and S2F . For consistency in these analyses, the significance of values is defined as follows: *p < 0.05, **p < 0.01, and ***p < 0.001.
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